Evidence map›Paper›PMID 33628447›Full record

ArticleSAGE open medical case reports2021

Differential onset time of mirtazapine on pruritus and depression in a patient receiving hemodialysis.

Yu Miyahara, Ayaka Haruta-Tsukamoto, Hideki Funahashi, Hisae Matsuo, Anna Kanemaru-Kawazoe, Toshikazu Nishimori, Yasushi Ishida

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Mirtazapine revisited: new therapeutic perspectives and formulation advances.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yu MiyaharaDepartment of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Ayaka Haruta-TsukamotoDepartment of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Hideki FunahashiDepartment of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Hisae MatsuoDepartment of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Anna Kanemaru-KawazoeDepartment of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Toshikazu NishimoriDepartment of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Yasushi IshidaDepartment of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.ORCID https://orcid.org/0000-0002-7601-4906
University of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 63-year-old male receiving hemodialysis for renal insufficiency developed severe and widespread pruritus, which was unresponsive to antihistamines and severe depression with insomnia, agitation, and anxiety. The oral administration of 7.5 mg mirtazapine daily alleviated his severe pruritus after 4 days and severe depression after 14 days. Mirtazapine has potential as a therapeutic option for patients receiving hemodialysis with depressive disorder and severe pruritus unresponsive to antihistamines.

Indexed as

depressionhemodialysisMirtazapinepruritus

Identifiers

PMID33628447
PMCPMC7841693
OpenAlexW3123434956

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.